201 related articles for article (PubMed ID: 24085769)
1. Structure of the factor VIII C2 domain in a ternary complex with 2 inhibitor antibodies reveals classical and nonclassical epitopes.
Walter JD; Werther RA; Brison CM; Cragerud RK; Healey JF; Meeks SL; Lollar P; Spiegel PC
Blood; 2013 Dec; 122(26):4270-8. PubMed ID: 24085769
[TBL] [Abstract][Full Text] [Related]
2. The 1.7 Å X-ray crystal structure of the porcine factor VIII C2 domain and binding analysis to anti-human C2 domain antibodies and phospholipid surfaces.
Brison CM; Mullen SM; Wuerth ME; Podolsky K; Cook M; Herman JA; Walter JD; Meeks SL; Spiegel PC
PLoS One; 2015; 10(3):e0122447. PubMed ID: 25775247
[TBL] [Abstract][Full Text] [Related]
3. Characterization and solution structure of the factor VIII C2 domain in a ternary complex with classical and non-classical inhibitor antibodies.
Walter JD; Werther RA; Polozova MS; Pohlman J; Healey JF; Meeks SL; Lollar P; Spiegel PC
J Biol Chem; 2013 Apr; 288(14):9905-9914. PubMed ID: 23417672
[TBL] [Abstract][Full Text] [Related]
4. Factor VIII inhibitor epitopes and an enigma.
Gilbert GE
Blood; 2013 Dec; 122(26):4160-1. PubMed ID: 24357711
[TBL] [Abstract][Full Text] [Related]
5. Structure of the Human Factor VIII C2 Domain in Complex with the 3E6 Inhibitory Antibody.
Wuerth ME; Cragerud RK; Spiegel PC
Sci Rep; 2015 Nov; 5():17216. PubMed ID: 26598467
[TBL] [Abstract][Full Text] [Related]
6. Residues Glu2181-Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII.
Healey JF; Barrow RT; Tamim HM; Lubin IM; Shima M; Scandella D; Lollar P
Blood; 1998 Nov; 92(10):3701-9. PubMed ID: 9808564
[TBL] [Abstract][Full Text] [Related]
7. Structure of Blood Coagulation Factor VIII in Complex With an Anti-C2 Domain Non-Classical, Pathogenic Antibody Inhibitor.
Ronayne EK; Peters SC; Gish JS; Wilson C; Spencer HT; Doering CB; Lollar P; Spiegel PC; Childers KC
Front Immunol; 2021; 12():697602. PubMed ID: 34177966
[TBL] [Abstract][Full Text] [Related]
8. Nonclassical anti-C2 domain antibodies are present in patients with factor VIII inhibitors.
Meeks SL; Healey JF; Parker ET; Barrow RT; Lollar P
Blood; 2008 Aug; 112(4):1151-3. PubMed ID: 18495957
[TBL] [Abstract][Full Text] [Related]
9. Antigenicity of putative phospholipid membrane-binding residues in factor VIII.
Barrow RT; Healey JF; Jacquemin MG; Saint-Remy JM; Lollar P
Blood; 2001 Jan; 97(1):169-74. PubMed ID: 11133757
[TBL] [Abstract][Full Text] [Related]
10. Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII.
Spiegel PC; Jacquemin M; Saint-Remy JM; Stoddard BL; Pratt KP
Blood; 2001 Jul; 98(1):13-9. PubMed ID: 11418455
[TBL] [Abstract][Full Text] [Related]
11. Antihuman factor VIII C2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation.
Meeks SL; Healey JF; Parker ET; Barrow RT; Lollar P
Blood; 2007 Dec; 110(13):4234-42. PubMed ID: 17848617
[TBL] [Abstract][Full Text] [Related]
12. Structure of blood coagulation factor VIII in complex with an anti-C1 domain pathogenic antibody inhibitor.
Gish JS; Jarvis L; Childers KC; Peters SC; Garrels CS; Smith IW; Spencer HT; Doering CB; Lollar P; Spiegel PC
Blood; 2021 May; 137(21):2981-2986. PubMed ID: 33529335
[TBL] [Abstract][Full Text] [Related]
13. Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII.
van den Brink EN; Bril WS; Turenhout EA; Zuurveld M; Bovenschen N; Peters M; Yee TT; Mertens K; Lewis DA; Ortel TL; Lollar P; Scandella D; Voorberg J
Blood; 2002 Apr; 99(8):2828-34. PubMed ID: 11929772
[TBL] [Abstract][Full Text] [Related]
14. Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site.
Pratt KP; Qian J; Ellaban E; Okita DK; Diethelm-Okita BM; Conti-Fine B; Scott DW
Thromb Haemost; 2004 Sep; 92(3):522-8. PubMed ID: 15351848
[TBL] [Abstract][Full Text] [Related]
15. Discontinuous epitopes on the C2 domain of coagulation Factor VIII mapped by computer-designed synthetic peptides.
Lebreton A; Moreau V; Lapalud P; Cayzac C; André S; Nguyen C; Schved JF; Lavigne G; Granier C
Br J Haematol; 2011 Nov; 155(4):487-97. PubMed ID: 21933172
[TBL] [Abstract][Full Text] [Related]
16. Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia A.
Kahle J; Orlowski A; Stichel D; Healey JF; Parker ET; Jacquemin M; Krause M; Tiede A; Schwabe D; Lollar P; Königs C
Blood; 2017 Aug; 130(6):808-816. PubMed ID: 28507083
[TBL] [Abstract][Full Text] [Related]
17. New characteristics of anti-factor VIII inhibitor antibody epitopes and unusual immune responses to Factor VIII.
Scandella D
Semin Thromb Hemost; 2002 Jun; 28(3):291-6. PubMed ID: 12098091
[TBL] [Abstract][Full Text] [Related]
18. Epitope specificity and inactivation mechanisms of factor VIII inhibitor antibodies.
Scandella D
Vox Sang; 1999; 77 Suppl 1():17-20. PubMed ID: 10529680
[TBL] [Abstract][Full Text] [Related]
19. Epitope repertoire of human CD4(+) T cells on the A3 domain of coagulation factor VIII.
Reding MT; Okita DK; Diethelm-Okita BM; Anderson TA; Conti-Fine BM
J Thromb Haemost; 2004 Aug; 2(8):1385-94. PubMed ID: 15304045
[TBL] [Abstract][Full Text] [Related]
20. Properties of anti-factor VIII inhibitor antibodies in hemophilia A patients.
Scandella DH
Semin Thromb Hemost; 2000; 26(2):137-42. PubMed ID: 10919405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
